SREENLIN Trademark

Trademark Overview

On Wednesday, February 8, 2017, a trademark application was filed for SREENLIN with the United States Patent and Trademark Office. The USPTO has given the SREENLIN trademark a serial number of 87328585. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2019. This trademark is owned by Shanghai Henlius Biotech, Inc.. The SREENLIN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-tumor drugs; anti-tumor drugs and drugs for treating autoimmune diseases
sreenlin

General Information

Serial Number87328585
Word MarkSREENLIN
Filing DateWednesday, February 8, 2017
Status700 - REGISTERED
Status DateTuesday, May 28, 2019
Registration Number5760202
Registration DateTuesday, May 28, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Goods and ServicesAnti-tumor drugs; anti-tumor drugs and drugs for treating autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShanghai Henlius Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameShanghai Henlius Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameShanghai Henlius Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Trademark Events

Event DateEvent Description
Monday, February 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 13, 2017NEW APPLICATION ENTERED
Wednesday, May 3, 2017ASSIGNED TO EXAMINER
Thursday, May 4, 2017NON-FINAL ACTION WRITTEN
Thursday, May 4, 2017NON-FINAL ACTION E-MAILED
Thursday, November 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 9, 2017SUSPENSION LETTER WRITTEN
Thursday, November 9, 2017LETTER OF SUSPENSION E-MAILED
Thursday, November 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 9, 2018SUSPENSION INQUIRY WRITTEN
Wednesday, May 9, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, May 9, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, November 5, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 5, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 16, 2018ASSIGNED TO LIE
Wednesday, November 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 30, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 4, 2018ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 18, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Saturday, January 26, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 26, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 31, 2019ASSIGNED TO PETITION STAFF
Saturday, February 2, 2019WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Saturday, February 2, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION

Related Keywords

sreenlin drugs tumor anti diseases treating autoimmune